The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents

This publication has 81 references indexed in Scilit:

• SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
  BMJ Open, 2016
• Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats
  Journal of Pharmacy and Pharmacology, 2014
• SYRCLE’s risk of bias tool for animal studies
  BMC Medical Research Methodology, 2014
• Smoking and Cardiovascular Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2014
• Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
  European Journal of Pharmacology, 2013
• Tumor necrosis factor-α: regulation of renal function and blood pressure
  American Journal of Physiology-Renal Physiology, 2013
• Macrophage-modulating cytokines predict adverse outcome in heart failure
  Thrombosis and Haemostasis, 2010
• Tumor Necrosis Factor-α and Mortality in Heart Failure
  Circulation, 2008
• C-Reactive Protein in Heart Failure
  Circulation, 2005
• Simple Heterogeneity Variance Estimation for Meta-Analysis
  Journal of the Royal Statistical Society Series C: Applied Statistics, 2005